KUALA LUMPUR: My E.G. Services Bhd
has entered into a memorandum of understanding with Anhui Zhifei Longcom Biopharmaceutical Co, Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.
MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
